These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4073009)

  • 21. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen P; Hall C; Marsh JC; Elebute M; Bombara MP; Petro BE; Cullen MJ; Richards SJ; Rollins SA; Mojcik CF; Rother RP
    N Engl J Med; 2004 Feb; 350(6):552-9. PubMed ID: 14762182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.
    Parker CJ; Soldato CM; Rosse WF
    J Clin Invest; 1984 Apr; 73(4):1130-43. PubMed ID: 6231312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relations between surface charge and in vitro lysis of red blood cells in paroxysmal nocturnal haemoglobinuria.
    Hause LL; Koethe SM; Rothwell DJ; Straumfjord JV
    Scand J Haematol; 1978 Feb; 20(2):141-6. PubMed ID: 635466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxysmal nocturnal hemoglobinuria: an historical overview.
    Parker CJ
    Hematology Am Soc Hematol Educ Program; 2008; ():93-103. PubMed ID: 19074065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in electrophoretic mobility pattern of erythrocytes in patients with paroxysmal nocturnal hemoglobinuria.
    Hayashi H; Fujii M; Yoshikumi C; Kawai Y; Watanabe N; Watanabe K; Fusama M; Shishido H
    J Clin Lab Immunol; 1987 Jun; 23(2):77-81. PubMed ID: 3625755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells.
    Logue GL; Rosse WF; Adams JP
    J Clin Invest; 1973 May; 52(5):1129-37. PubMed ID: 4700488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipids of the erythrocyte in paroxysmal nocturnal hemoglobinuria.
    Gockerman JP
    Am J Hematol; 1978; 5(4):323-33. PubMed ID: 753102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
    Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
    J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.
    Schultz DR
    Am J Med; 1989 Sep; 87(3N):22N-29N. PubMed ID: 2484793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.
    Aster RH; Enright SE
    J Clin Invest; 1969 Jul; 48(7):1199-210. PubMed ID: 5798625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA).
    Ninomiya H; Abe T; Shichishima T; Terasawa T; Fujita T
    Br J Haematol; 1988 May; 69(1):81-7. PubMed ID: 2454648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface charge of erythrocytes in paroxysmal nocturnal haemogloninuria.
    Rothwell DJ; Hause LL; Koethe S; Straumfjord JV
    Scand J Haematol; 1976 Apr; 16(4):241-4. PubMed ID: 935806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor.
    Okada N; Harada R; Okada H
    Clin Exp Immunol; 1990 Apr; 80(1):109-13. PubMed ID: 1691059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the enhanced susceptibility of paroxysmal nocturnal hemoglobinuria erythrocytes to complement-mediated hemolysis initiated by cobra venom factor.
    Parker CJ; Stone OL; Bernshaw NJ
    J Immunol; 1989 Jan; 142(1):208-16. PubMed ID: 2909615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RBC transfusions in paroxysmal nocturnal hemoglobinuria.
    Gockerman JP; Brouillard RP
    Arch Intern Med; 1977 Apr; 137(4):536-8. PubMed ID: 849085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiology of disease in patients with paroxysmal nocturnal hemoglobinuria.
    Bessler M; Hiken J
    Hematology Am Soc Hematol Educ Program; 2008; ():104-10. PubMed ID: 19074066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.